Money & Business Structure
Can I raise investment with just a patent and no product?
The short answer
Yes — it happens systematically, not just occasionally. University licensing data shows licenses with startups grew 15% and agreements including equity grew 16% in 2025: investors routinely take equity positions anchored on IP before a product exists.
The full picture
What makes IP-only raises work: a credible market, a team (or an honest plan to rent one), and a patent that maps to the opportunity. Investors aren't buying the patent — they're buying a defensible position in a market, with the patent as the moat. Your job is showing the moat actually guards something valuable.
The realistic expectations: pre-product valuations are modest, dilution is real, and diligence on IP is serious — investors' counsel will read your claims. Walking in with a commercialization score and a market analysis converts 'trust me' into 'review this,' which changes the tone of the entire raise. That preparation is exactly what we're built for.
Where does your patent stand?
The Beyond the Patent Commercialization Score answers that — a professional, factor-by-factor read on your patent's licensing, sale, build, and partner potential.
Related questions
General information for patent owners — not legal advice. Read the disclaimer.